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A B S T R A C T   
Assessing the ability of pharmaceutics to cross biological barriers and reach the site-of-action requires faithful 
representation of these barriers in vitro. Difficulties have arisen in replicating in vivo resistance in vitro. This paper 
investigated serum starvation as a method to increase Caco-2 barrier stability and resistance. The effect of serum 
starvation on tight junction production was examined using transwell models; specifically, transendothelial 
electrical resistance (TEER), and the expression and localization of tight junction proteins, occludin and zonula 
occludens-1 (ZO-1), were studied using western blotting and immunofluorescence. Changing cells to serum-free 
media 2 days post-seeding resulted in TEER readings of nearly 5000 Ω cm2 but the TEER rapidly declined 
subsequently. Meanwhile, exchanging cells to serum-free media 4–6 days post-seeding produced barriers with 
resistance readings between 3000 and 4000 Ω cm2, which could be maintained for 18 days. This corresponded to 
an increase in occludin levels. Serum starvation as a means of barrier formation is simple, reproducible, and cost- 
effective. It could feasibly be implemented in a variety of pre-clinical pharmaceutical assessments of drug 
permeability across various biological barriers with the view to improving the clinical translation of novel 
therapeutics.   
1. Introduction 
During drug development, the solubility and permeability of drug 
compounds are considered major factors contributing to drug bioavail-
ability and efficacy [1]. Processes are now being implemented to 
improve the water solubility of drugs [2]; however, this can pose new 
problems for drug permeability. For drugs to reach their intended 
site-of-action at therapeutic levels, they may have to cross a number of 
biological barriers [3] such as the gastrointestinal barrier, blood-brain 
barrier, blood-cerebrospinal fluid barrier, blood-ocular/blood-retinal 
barrier, and blood-testis/blood-epididymal barrier [4,5]. Transport of 
drugs across these barriers proceeds via two routes: transcellular and 
paracellular pathways [3]. The transcellular route is typically favored by 
lipophilic compounds, while hydrophilic compounds tend to cross via 
the paracellular route [3]. Thus, the development of more water-soluble 
drugs means that paracellular transport across biological barriers must 
be improved. 
In vitro models are widely used in early assessments of drug perme-
ation in an effort to reduce reliance on animal models for pre-clinical 
testing [6]. Here, paracellular transport is modulated by tight junc-
tions [3] which prevent passive diffusion of molecules between adjacent 
barrier cells [7]. Transendothelial electrical resistance (TEER) is 
commonly employed to assess the resistance of these models to para-
cellular diffusion. The accuracy of these models relies on faithful rep-
resentation of tight junctional complexes. Often, these models 
underproduce tight junction proteins, resulting in more permeable 
barriers than their in vivo counterparts. For example, in the context of 
the blood-brain barrier (BBB), TEER values in vivo have been measured 
between 2000 and 6000 Ω cm2[8,9]. Although, based on solute 
permeation coefficients, it has also been calculated to be as high as 8000 
Ω cm2[10]. However, there is a consensus in the field that TEER values 
above 150 Ω cm2 are considered to have acceptable resistance to 
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conduct in vitro permeability studies [11,12]. 
Estimating the permeability of drugs using in vitro barriers with low 
resistance may not be effective in predicting in vivo bioavailability. At-
tempts to improve TEER values in models include co-culturing [13–21], 
treatment with extracellular matrix components [20–23] and applica-
tion of fluid flow [20,21,24,25]. However, these methods are costly and 
labor intensive, and still may not recapitulate in vivo barrier resistance. 
One method used to alter the expression of tight junction proteins in 
vitro is serum starvation. The presence of serum in barrier cultures has 
been shown to prevent tight junction formation thereby reducing TEER 
values and increasing paracellular transport [26]. In this paper, we 
investigated the effect of serum-free media on the formation of restric-
tive monolayers in Caco-2 cells as a simple model for in vitro barrier 
formation. Caco-2 cells are gastrointestinal epithelialia established from 
a human colorectal adenocarcinoma. These cells have been used 
extensively for the last 40 years to study polarized barriers and drug 
permeability [27]. Given the extensive research conducted using these 
cells, they are a useful model to study conditions affecting barrier 
permeability. We hypothesized that a period of culture in serum con-
taining media would allow time for monolayer formation. Following this 
with a period of culture in serum-free media would result in differenti-
ation of the cells, thereby improving tight junction formaton and 
increasing barrier resistance. In doing so, we explored the effect of 
serum-containing and serum-free culture conditions on the expression 
and localization of extracellular and intracellular tight junction protein, 
occludin and zonula occludens-1 (ZO-1), respectively. The formation of 
simple, reproducible, and cost-effective models of biological barriers 
will improve the accuracy of pre-clinical in vitro evaluation of medica-
tions [28]. 
2. Materials and methods 
2.1. Cell culture 
Caco-2 cells (Sigma Aldrich 86010202) were maintained in complete 
culture medium (CCM) [DMEM (Sigma Aldrich D6546) with 10 % FBS 
(Sigma Aldrich F7524), 1 % non-essential amino acids (Sigma Aldrich 
M7145), 2 mM L-glutamine (Sigma Aldrich G7513), and 100 units/mL 
penicillin and 100 μg/mL streptomycin (Sigma Aldrich P4333)] as 
described by Lea (2015) [27]. 
2.2. Transwell model 
The apical side of a 0.4 μm pore, polycarbonate 12-well transwell 
(Corning 3401) was seeded with Caco-2 cell suspension (passage 4–6) (1 
× 105 cells/transwell, 8.9 × 104 cells/cm2). After a period of culture in 
CCM, cells were transferred to serum-free (SF) culture medium [DMEM 
supplemented with 1 % non-essential amino acids, 2 mM L-glutamine, 
100 units/mL penicillin and 100 μg/mL streptomycin]. To determine the 
optimal timepoint for transfer to SF culture medium, in different 
transwells CCM was exchanged for SF on a day between 0 and 20 days in 
culture. Cells were all maintained in culture until Day 40 (where Day 0 is 
the day of seeding). 
2.3. Transendothelial electrical resistance 
Every two days TEER of the cell barrier was measured using the 
EVOM2 (World-Precision Instruments, United Kingdom) as described by 
Yeste et al. (2018) [29]. The resistance of a blank well (membrane with 
no cells) was recorded as a background reading and subtracted from the 
measured resistance values. This value was multiplied by the membrane 
surface area (1.12 cm2) to calculate the TEER. Three measurements were 
acquired for each well. Conditions were tested in triplicate across three 
separate experiments. TEER results are presented as the mean ± stan-
dard deviation. 
2.4. Immunoblotting 
Immunoblotting was carried out similar to the method described in 
Walsh et al. (2018) [30]. For immunoblotting experiments, Caco-2 cells 
(passage 5–8) were seeded in 6-well plates (Corning 3516) at 8.9 × 104 
cells/cm2. Following culture, cells were collected and lysed on ice for 30 
min [Note: SFD0 samples (cells exchanged to SF media on Day 0 and 
collected the same day) were collected 2 h post-seeding]. Protein con-
tent was quantified using a bicinchonic acid assay (Fisher Scientific 
23225). 
Samples containing 15 μg of protein were prepared with 1x LDS 
sample buffer (Invitrogen B0007) and 2.5 % β-mercaptoethanol and 
heated to 95 ◦C for 5 min. Samples were run on 4–12 % Bis-Tris gels 
(Invitrogen NW04125BOX) using 1x MOPS running buffer (Invitrogen 
B0001). Gels were transferred to nitrocellulose membranes (GE 
Healthcare Amershem Protran 10600003). For GAPDH and occludin, 
gels were transferred at 100 V for 1 h at 4 ◦C in transfer buffer. For ZO-1, 
gels were transferred in transfer buffer containing 0.1 % w/v SDS for 1.5 
h at 100 V at 4 ◦C. Membranes were blocked for 1 h at room temperature 
(RT) in 5 % skim milk in tris-buffer saline-0.1 % tween 20 and probed 
overnight at 4 ◦C with primary antibody (Supplementary Material [SM]- 
Table S1). The membranes were incubated for 1 h at RT with secondary 
antibody (SM-Table S1). Membranes were imaged using the LI-COR 
Odyssey. Triplicate experiments were conducted. 
Densitometry was conducted using the LI-COR Image Studio Lite 
(version 5.2). The intensity of ZO-1 and occludin were normalized 
against GAPDH. All intensity values were expressed relative to the SFD0 
sample. The mean normalized relative intensity was calculated across 
triplicate experiments. 
2.5. Immunofluorescence 
Caco-2 cells (passage 5–8) were seeded in 96-well plate (Corning 
3599) at a concentration of 8.9 × 104 cells/cm2. After culturing, 
immunofluorescene was carried our using a similar technique to that 
employed by De Benedictis et al. (2021) [31]. Briefly, cells were fixed for 
15 min in a 4 % formaldehyde (Note: SFD0 samples were fixed 2 h 
post-seeding). Cells were permeabilised for 15 min at RT in 0.5 % Triton 
X-100 in PBS and blocked for 1 h at RT with 1x PBS containing 10 % FBS, 
0.005 % Triton X-100. Cells were probed for occludin or ZO-1 
(SM-Table S1) overnight at 4 ◦C. Cells were incubated with secondary 
antibody (SM-Table S1) for 1 h at RT followed by a 10 min incubation 
with 0.1 μg/mL DAPI (Sigma Aldrich D9542). Cells were imaged using 
the ImageXpress Microconfocal High-Content Imaging System (Molec-
ular Devices). Experimental conditions were examined in triplicate 
across three separate experiments. 9 images were acquired per well. The 
images were analyzed utilizing CellProfiler (version 3.1.8) [32]. Image 
analysis protocol is detailed in SM-Section 4.1. 
2.6. Statistical analysis 
Statistical analysis was carried out using Graphpad Prism 6 (version 
8.3.1). For immunoblot analysis, normalized protein levels are 
expressed as mean normalized relative intensity ± standard error about 
the mean (SEM). Mean protein levels were compared using one-way 
analysis of variance (ANOVA) at a 95 % confidence interval with 
Sidak’s multiple comparisons test. Correlations between protein levels 
and TEER values were analyzed using both Pearson’s and Spearman’s 
correlations. Spearman’s correlation was used to compare the protein 
levels and corresponding TEER values at the same time point. Mean-
while, Pearson’s correlation was used to compare proteins levels at the 
time the cells were transferred to SF media and the maximum TEER 
values. 
For immunofluorescence, the normalized protein intensity for each 
image was compared to others from the same well using the ROUT 
outliers test (Q = 1) and outliers were excluded. Mean intensities for 
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replicate wells were similarly compared. All intensity values were 
expressed as mean ± SEM. Mean intensities were compared using one- 
way ANOVA using a 95 % confidence interval with Sidak’s multiple 
comparisons test. 
3. Results 
A number of methods were utilized to assess the role of serum-free 
(SF) media on tight junctions formation in Caco-2 monolayers. In 
addition to using TEER to determine monolayer resistance, the impact of 
serum on tight junction protein expression and sub-cellular localization 
was investigated. 
3.1. Changes in TEER in response to serum-containing and serum-free 
media 
Culture in SF media has been shown to increase barrier resistance to 
paracellular transport in vitro [26,33]. We sought to investigate this in 
the context of Caco-2 barriers. To evaluate the formation of a restrictive 
barrier, TEER was measured every 2 days for 40 days (Fig. 1). 
Based on this assessment, switching to SF media early in the culture 
period (SFD0, SFD2) resulted in the highest maximum TEER (Fig. 1a and 
b; SM-Table S2). However, the measurements showed significant vari-
ability and values subsequently decreased rapidly. 
Instead, cells exchanged to SF media on day 4–6 (Fig. 1c and d) 
Fig. 1. Transendothelial electrical resistance (TEER) of cell barriers was measured every 2 days using the EVOM2. Complete culture media (CCM) was exchanged for 
serum-free (SF) media on different days (e.g. SFD4 denotes that media was exchanged to serum-free media following 4 days in CCM). The period of the graphs 
relating to culture in CCM is highlighted in red and culture in SF media is highlighted in blue. Data points represent the mean of triplicate measurements across 
triplicate wells from triplicate experiments (n = 27). Error bars denote standard deviation. (For interpretation of the references to color in this figure legend, the 
reader is referred to the Web version of this article.) 
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achieved TEER measurements between 3000 and 4000 Ω cm2. These 
measurements showed lower standard deviations and the barriers 
remained above 3000 Ω cm2 for over 2 weeks. 
Meanwhile, longer periods of culture in CCM prior to exchanging for 
SF media resulted in lower and more variable TEER values (Fig. 1e–k). 
When exchanging to SF media on D20, TEER values are not higher than 
wells maintained in CCM for the duration (Fig. 1k-l). 
3.2. Occludin and ZO-1 expression and barrier formation 
To investigate the reason for these changes in TEER, we conducted 
immunoblot analysis of the levels of tight junction proteins, occludin 
and ZO-1 (Fig. 2) (raw immunoblots in SM-Fig. S1). We analyzed protein 
expression levels every 2 days from D0-D20 and at the point that the 
respective cultures achieved maximum TEER. In this way, we could 
analyze:  
1. Changes in protein levels over 20 days in CCM i.e. SFD0, SFD2, etc.,  
2. Protein levels before switching to SF media compared to when 
maximum TEER was achieved (e.g. SFD0 vs SFD0-Max),  
3. The relationship between protein levels and TEER. 
Immunoblotting showed that ZO-1 levels increase early in the cul-
ture period with maximum ZO-1 expression occurring on D2 (Fig. 2a&c; 
SFD2). After this, ZO-1 levels decrease and remain relatively stable with 
no significant variation in the quantity of ZO-1 (Fig. 2c; red bars). The 
transfer of cells to SF media resulted in no significant alteration of ZO-1 
levels, with the exception of those transferred to SF media on D2 (SFD2 
vs SFD2-Max); here there was a significant decrease in ZO-1 levels be-
tween levels on day 2 (SFD2) and the day this culture reached maximum 
TEER (SFD2-Max) (Fig. 2c). 
We compared the expression of ZO-1 in cultures of CCM and SF 
media, analyzed after the same total culture time (Fig. 2d). This showed 
that there was no significant difference between different culture con-
ditions, analyzed after the same length of culture. Thus, we concluded 
that SF media does not appear to effect ZO-1 expression. 
Conversely, occludin levels are relatively low in CCM. A significant 
difference between protein levels on the day the culture is exchanged to 
SF media and the point the culture reach maximum TEER can be seen 
(Fig. 2b&f). 
To investigate whether this resulted from a longer culture period or a 
response to SF conditions, we examined the expression of occludin be-
tween cultures in CCM and SF media, analyzed after the same length of 
time in culture (Fig. 2g). SFD16 was analyzed following 16 days culture 
in CCM, while SFD4-Max, SFD6-Max, and SFD8-Max had been cultured 
in SF media for 12, 10 and 8 days, respectively, for a total 16 days in 
culture; therefore, these experimental conditions had been in culture for 
the same length of time but in different conditions. This showed that 
there was a significant difference between SFD16 and SFD4-Max (p =
0.0003), SFD16 and SFD6-Max (p = 0.0027), and SFD16 and SFD8-Max 
(p = 0.0460), with the largest difference corresponding to the longest 
period in SF media (SFD16 vs SFD4-Max). This indicated that greater 
levels of occludin expression resulted from SF conditions not increased 
culturing time. 
To examine the relationship between tight junction expression and 
barrier resistance, we investigated the correlation between relative 
protein levels and TEER. Occludin levels significantly correlated to 
TEER (ρ = 0.7561, p > 0.0001) (Fig. 2h). However, ZO-1 levels showed 
no significant correlation (ρ = 0.04122, p = 0.8555; SM-Fig. S2a). 
Interestingly, since ZO-1 was largely expressed in CCM conditions, we 
investigated the correlation between the ZO-1 levels at the time of ex-
change to SF media and the maximum TEER values. This showed that 
there was a significant correlation between the ZO-1 levels when the 
cultures were transferred to SF media and the maximum TEER achieved 
(r = 0.8010, p = 0.0054) (Fig. 2e). This was not seen for occludin (SM- 
Fig. S2b). 
3.3. Localization of occludin and ZO-1 in barrier resistance 
Increased tight junction expression alone is not sufficient for barrier 
resistance; localization of these proteins to the cell membrane is neces-
sary. When protein localization is considered, it is evident that in cul-
tures maintained in serum-containing media for extended periods (over 
10 days), occludin localization becomes more diffuse or punctate 
(Fig. 3Bi). The optimum localization in serum-containing media is seen 
in the early cultures (SM-Fig. S5). Meanwhile, samples that had been 
cultured SF media show improved localization of occludin to the cell 
membrane, even after 10 days (e.g. SFD2-Max (Fig. 3Bii)). 
Conversely, for ZO-1, as with immunoblot analysis, protein locali-
zation does not appear to be serum-dependent. There is no distinct dif-
ference between cell membrane localization in CCM compared to SF 
media (SM-Fig. S4). Instead, it appears that the early cultures (SFD0, 
SFD2, SFD4) (Fig. 3Ai) show more diffuse staining with localization 
becoming more pronounced in the later days (SFD14-SFD20 and SFD10- 
Max to SFD18-Max) irrespective of culture media (Fig. 3Aii). Staining 
can still be seen within the cytoplasm but we attribute this to continuous 
production of the protein. 
The relative signal intensity of each protein (normalized by number 
of cells) was compared (Fig. 4b). Occludin levels show different 
expression patterns to those seen in the immunoblot analysis (Fig. 4c). 
The mismatch between immunoblot and immunofluorescence results 
may be due to epitope accessibility. In the serum-containing cultures, 
occludin is more diffuse and, thus, the occludin epitope is more acces-
sible for antibody binding. Meanwhile, in the serum-free conditions, 
occludin localization to the cell membrane results in compact, complex 
protein interactions which may shield extracellular epitopes from anti-
body binding [34]. Hence, in these conditions, total protein could be 
underestimated. 
4. Discussion 
Serum starvation is believed to improve barrier formation by 
reducing proliferation and promoting cell differentiation [33,35,36] 
thereby increasing barrier formation and reducing permeability [33]. 
Factors derived from serum are reported to destabilize already formed 
tight junctions, thereby increasing model permeability [26,37]. We 
postulated that a period of culture in serum-containing media is initially 
required to promote cell proliferation and initial barrier formation. This 
would then be followed by a period in SF media to promote increased 
cell differentiation, tight junction expression and localization. Extended 
time in serum-containing media could result in de-differentiation of the 
cells while premature transfer to SF condition could lead to poor 
monolayer formation. Therefore, we considered that the balance be-
tween culture in serum-containing and serum-free media would affect 
the quantity and quality of the tight junctions formed. 
The results presented here show that a period of 4 days in CCM 
followed by 6–12 days in SF media resulted in the most stable and 
restrictive barrier. We believe that these conditions facilitated complete 
monolayer formation (immunofluorescence) and optimum expression of 
occludin and ZO-1 (immunoblotting). 
Occludin is a critical transmembrane tight junction protein [38,39], 
forming homocomplexes with neighboring cells [40]. This is believed to 
be responsible for establishing a seal at the site of junctional complexes 
[3]. ZO-1, unlike occludin, is an intracellular protein involved in 
anchoring occludin and other tight junction proteins to the cytoskeleton, 
providing stability to junctional complexes [39,41]. As expected, 
occludin levels were found to correlate significantly with TEER and 
corresponded to the conditions that resulted in the most restrictive and 
stable barrier formation. This indicates that occludin levels not only 
confer increased resistance but also lead to increased barrier stability, 
likely resulting from improved extracellular complexes. 
It is possible that the increased occludin levels are the result of 
activation of a p38 MAPK pathway. p38 mitogen-activated protein 
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Fig. 2. Immunoblot analysis of ZO-1 and occludin levels. Representative immunoblot showing (a) ZO-1 and (b) occludin with GAPDH as an internal control. (c) 
Relative ZO-1 levels (relative to SFD0; n = 3). (d) Relative ZO-1 levels grouped according to days in culture at the time of analysis. (e) Correlation between relative 
ZO-1 levels at the time the cultures are transferred to SF media and maximum TEER. (f) Relative occludin levels (relative to SFD0; n = 3). (g) Relative occludin levels 
grouped according to days in culture at the time of analysis. (h) Correlation between relative occludin levels and TEER. SF=Serum-free, D = day; SFD0 = cells 
collected on D0; SFD0-Max = cells exchanged to serum-free media on day 0, collected on the day these cultures achieve maximum resistance. Bars in red represent 
cultures in CCM; bars in blue represent protein levels at maximum TEER values after culture in SF media, with the exception of SFD20-Max (blue and red hatched 
bar) which reached maximum TEER in CCM before transfer to SF media. Bars represent the mean (n = 3) and error bars represent SEM. * = 0.05 > p > 0.01; ** =
0.01 > p > 0.001; *** = 0.001 > p > 0.0001; **** = 0.0001 > p. (For interpretation of the references to color in this figure legend, the reader is referred to the Web 
version of this article.) 
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kinases (MAPKs) are MAPK isoforms that are involved in cell differen-
tiation [42] and stress response [43]. It has been shown previously that 
endostatin can act in a p38 MAPK and ERK1/2 (extracellular 
signal-regulated kinase) dependent manner to upregulate occludin 
expression and hence decrease barrier permeability in a blood-retinal 
barrier model [42,44]. Further, it has also been shown that serum 
starvation can induce phosphorylation of p38 [45,46] in addition to 
activation of ERK-1 and ERK-2 [47]. Taken together, these results may 
suggest that serum-starvation here induced an increase in occludin 
expression and corresponding decrease in permeability through activa-
tion of a p38 MAPK and ERK1/2 pathway. However, further testing 
would be required to elucidate the involvement of this pathway. 
We expected to see a similar trend for ZO-1 expression. However, 
instead we found that ZO-1 levels did not change significantly following 
transfer to SF media. The highest levels of ZO-1 occurred on D0 and D2. 
It is worth noting that the variability seen in the ZO-1 samples in the 
initial days of culture is likely the result of ZO-1 present in the cells at the 
time the experiment was established. For occludin, as the protein con-
tains an extracellular portion, during sub-culturing the protein will 
likely be fragmented by trypsin [48]. It will then be synthesized de novo 
following experimental set-up. This is supported by the low levels of 
occludin at D0 which steadily increased throughout the experiment. 
Conversely, ZO-1 is an intracellular protein and would not be digested 
by trypsin. Therefore, D0 levels are likely to be related to the ZO-1 levels 
within the cells at the time of experimental set-up. This resulted in 
higher initial ZO-1 levels than expected and greater inter-experiment 
variability. After this, ZO-1 levels decrease and remain relatively sta-
ble regardless of SF or CCM culture conditions. This would indicate that 
ZO-1, unlike occludin, is not stimulated by SF conditions but it is 
produced consistently in CCM or SF media. 
ZO-1 plays a role in the organization of the tight junctions, traf-
ficking occludin to the membrane in the early days of barrier formation 
[41]. Previously, when cells are transfected with occludin, the protein 
cannot be trafficked to the cell membrane in the absence of ZO-1 [49, 
50]. Our results support this concept; while ZO-1 levels do not directly 
correlate to TEER, the presence of increased levels of ZO-1 at the point 
the cultures are switched to SF media could be involved in trafficking the 
newly formed occludin to the cell membrane. Thus, ZO-1 levels are 
likely to correspond indirectly to barrier resistance. Meanwhile, 
increased occludin correlated directly to improved barrier resistance 
and stability. 
In addition to the use of in vitro models, such as the model described 
here, to directly assess drug permeability across biological barrier, such 
models could also be used in conjunction with computational models of 
barrier permeability [51]. The use of in silico models has increased in the 
last 20 years with continuous improvements on modeling capabilities 
and machine learning [52,53]. Computational models utilize in vivo and 
in vitro data to inform modeling and improve prediction capabilities 
[53–55]. Better in vitro models can provide a better understanding of the 
mechanisms by which drugs permeate across biological barriers [54]. 
Together improved in vitro and in silico models can work synergistically 
to reduce our reliance on animal models in the drug development 
process. 
5. Conclusions 
Utilizing unrealistic, “leaky” in vitro barrier models will over- 
estimate pharmaceutical paracellular permeation across biological 
Fig. 3. Representative immunofluorescence images 
of ZO-1 and occludin. Representative images of (A) 
ZO-1 (red) at (i) an early time point (SFD4) and (ii) 
a late time point (SFD18-Max), and of (B) occludin 
(green) maintained in (i) serum containing media 
(CCM-Max) and (ii) transferred to SF media (SFD2- 
Max). Scale bar = 100 μm. SF=Serum-free, D = day; 
D0 = cells changed to SF media on Day 0; SFD0 =
cells exchanged to SF media on day 0, fixed that day 
i.e. on day 0; SFD0-Max = cells exchanged to 
serum-free media on day 0, fixed on the day these 
cultures achieve maximum resistance. (For inter-
pretation of the references to color in this figure 
legend, the reader is referred to the Web version of 
this article.)   
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barriers, ultimately wasting time and money. Here, we investigated the 
effects of serum starvation on Caco-2 cell barrier formation. We found 
that exchanging cells from serum-containing media to serum-free media 
on day 4 resulted in TEER values of 3000–4000 Ω cm2 which could be 
maintained for >2 weeks. We have attributed this increase in resistance 
to higher levels of occludin caused by serum starvation. Newly formed 
occludin is likely trafficked to the cell membrane by ZO-1; ZO-1 levels 
seem to indirectly correlate with maximum TEER. However, ZO-1 does 
not appear to be affected by serum levels, directly. To conclude, serum 
starvation could be a simple, rapid, reproducible, and cost-effective 
method to prepare biological barrier models. Such models could be 
easily implemented in preliminary pharmaceutical assessments to 
evaluate the ability of novel therapeutics to reach their site-of-action at 
clinically significant levels. 
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